)
)
Ocular Therapeutix Investor Relations Material
Latest events
Q4 2024
Ocular Therapeutix
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Ocular Therapeutix Inc
Access all reports
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company offers Rhopressa (generic name: tetrahydroprochlorothiazide/timolol maleate) for the treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
OCUL
Country
🇺🇸 United States